Red blood cell distribution width and long-term outcome in patients undergoing percutaneous coronary intervention in the drug-eluting stenting era: A two-year cohort study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yao, Hai Mu ^a   Sun, Tong Wen ^a   Zhang, Xiao Juan ^a   Shen, De Liang ^a   Du, You You ^a   Wan, You Dong ^a   Zhang, Jin Ying ^a   Li, Ling ^a   Zhao, Luo Sha ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; ERYTHROCYTE; FEMALE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RED BLOOD CELL DISTRIBUTION WIDTH; STENT THROMBOSIS; AGED; BLOOD; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; MORTALITY; PROGNOSIS; REGISTER; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REGISTRIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84899508641     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094887     Document Type: Article

References (32)

1. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, et al. (2008) Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation 117: 163-168.
2. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, et al. (2010) Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 16: 230-238.
3. Dabbah S, Hammerman H, Markiewicz W, Aronson D (2010) Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105: 312-317.
4. Poludasu S, Marmur JD, Weedon J, Khan W, Cavusoglu E (2009) Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention. Thromb Haemost 102: 581-587.
5. Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, et al. (2010) Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol 141: 141-146.
6. Fatemi O, Paranilam J, Rainow A, Kennedy K, Choi J, et al. (2013) Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis 35: 57-64.
7. Lippi G, Filippozzi L, Montagnana M, Salvagno GL, Franchini M, et al. (2009) Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med 47: 353-357.
8. Wang YL, Hua Q, Bai CR, Tang Q (2011) Relationship between red cell distribution width and short-term outcomes in acute coronary syndrome in a Chinese population. Intern Med 50: 2941-2945.
9. Chen PC, Sung FC, Chien KL, Hsu HC, Su TC, et al. (2010) Red Blood Cell Distribution Width and Risk of Cardiovascular Events and Mortality in a Community Cohort in Taiwan. Am J Epidemiol 171: 214-220.
10. (1968) Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405: 5-37.
11. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
12. (2007) Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation 115: 2344-2351.
13. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, et al. (2003) Bivalrudin and provisional. glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: the REPLACE-2 randomized trial. JAMA 289: 853-63. (Pubitemid 37430344)
14. Arbel Y, Birati EY, Finkelstein A, Halkin A, Berliner S, et al. (2013) Red blood cell distribution width and 3-year outcome in patients undergoing cardiac catheterization. J Thromb Thrombolysis [Epub ahead of print]
15. Moses JW, Leon M B, Popma JJ, Fitzgerald PJ, Holmes DR, et al. (2008) Sirolimus -eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349: 1315-1323.
16. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, et al. (2004) A polymer-based, paclitaxel-eluting stent inpatients with coronary artery disease. N Engl J Med. 350: 221-231. (Pubitemid 38067635)
17. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, et al. (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50: 40-47. (Pubitemid 46963527)
18. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, et al. (2005) Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111: 2042-2049. (Pubitemid 40577898)
19. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, et al. (2005) A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 165: 2214-2220. (Pubitemid 41549915)
20. Arbel Y, Weitzman D, Raz R, Steinvil A, Zeltser D, et al. (2014) Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thromb Haemost 111: 300-307.
21. Fatemi O, Torguson R, Chen F, Ahmad S, Badr S, et al. (2013) Red cell distribution width as a bleeding predictor after percutaneous coronary intervention. Am Heart J 166: 104-9.
22. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, et al. (2008) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133: 628-32.
23. Klein LW, Arrieta-Garcia C (2012) Is patient frailty the unmeasured confounder that connects subacute stent thrombosis with increased periprocedural bleeding and increased mortality? J Am Coll Cardiol 59: 1760-1762.
24. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, et al. (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162: 2333-2341. (Pubitemid 35332516)
25. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, et al. (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85: 3144-3149.
26. Abou-Saleh H, Yacoub D, Theoret JF, Gillis MA, Neagoe PE, et al. (2009) Endothelial progenitor cells bind and inhibit platelet function and thrombus formation. Circulation 120: 2230-2239.
27. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
28. Veeranna V, Zalawadiya SK, Panaich S, Patel KV, Afonso L (2013) Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population:Findings from the 1999-2004 NHANES. Int J Cardiol 168: 5156-5161
29. Minetti M, Agati L, Malorni W (2007) The microenvironment can shift erythrocytes from a friendly to a harmful behavior: pathogenetic implications for vascular diseases. Cardiovasc Res 75: 21-8. (Pubitemid 46873513)
30. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM (2009) Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 169: 515-23.
31. Nabais S, Losa N, Gaspar A, Rocha S, Costa J, et al. (2009) Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes. Rev Port Cardiol 28: 905-924.
32. Ward MJ, Boyd JS, Harger NJ, Deledda JM, Smith CL, et al. (2012) An automated dispensing system for improving medication timing in the emergency department. World J Emerg Med 3: 102-107.